Information Journal Paper
APA:
Copy. (2019). Co-delivery of cisplatin and doxorubicin by covalently conjugating with polyamidoamine dendrimer for enhanced synergistic cancer therapy. ACTA BIOMATERIALIA, 84(-), 367-377. SID. https://sid.ir/paper/709756/en
Vancouver:
Copy. Co-delivery of cisplatin and doxorubicin by covalently conjugating with polyamidoamine dendrimer for enhanced synergistic cancer therapy. ACTA BIOMATERIALIA[Internet]. 2019;84(-):367-377. Available from: https://sid.ir/paper/709756/en
IEEE:
Copy, “Co-delivery of cisplatin and doxorubicin by covalently conjugating with polyamidoamine dendrimer for enhanced synergistic cancer therapy,” ACTA BIOMATERIALIA, vol. 84, no. -, pp. 367–377, 2019, [Online]. Available: https://sid.ir/paper/709756/en